CVR 46702255Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)HellerupFounded 17 Aug 2026
CVR holds no employment figures for this company.
CVR holds no annual report for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Lica Pharma ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexKarin Birgitte Sonne Kharazmi50% to under 66.7% of capital and votes, since 17 Aug 2026
Arsalan Kharazmi50% to under 66.7% of capital and votes, since 17 Aug 2026
Operating company
Dandex estimate: no recent employees or annual report figures to go onMark Sonne Kharazmisince 17 Aug 2026
50% to under 66.7% of capital and votessince 17 Aug 2026
50% to under 66.7% of capital and votessince 17 Aug 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Decided by Dandex with fixed rules from CVR and the filed annual reports, not registered by the company. Each label links to its definition.
17 Aug 2026 to 12 Nov 2026.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For Lica Pharma ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
Demerger (spaltning), as the receiving company (modtagende selskab)
From CVR, read 12 Nov 2026. Text such as the signing rule and purpose is shown as registered.
2 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Ny adresse: c/o Kharazmi, Tuborg Havnepark 2, 1. tv, 2900 Hellerup
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en spaltningsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende virksomheder må antages at være tilstrækkeligt sikrede efter spaltningen.
Virksomheden er d. 17.08.2026 opstået efter spaltning. Aktiver og gæld er overdraget fra CVR-nummer: 25332520 LICA PHARMACEUTICALS ApS, der samtidigt er opløst.
Seneste vedtægtsdato: 17.08.2026.
Kapital:
kr. 20.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt ved spaltning kr. 20.000,00 til kurs 88.647,29, fuldt indbetalt.
Bestyrelse:
Arsalan Kharazmi, (formand), den 17.08.2026, Karin Birgitte Sonne Kharazmi, den 17.08.2026, Mark Sonne Kharazmi, den 17.08.2026.
Direktion:
Mark Sonne Kharazmi, den 17.08.2026.
Selskabet tegnes af en direktør.
Første regnskabsår:
01.01.2026 - 31.12.2026.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive virksomhed med forskning indenfor medicinalbranchen og hermed beslægtet virksomhed med henblik på kommerciel udnyttelse og salg af forskningsresultaterne. Overskydende kapital investeres løbende efter ledelsens vurdering.
1 registered in CVR.
P-number 1032683572Tuborg Havnepark 2, 2900 Hellerup
